×
About 1,061 results

ALLMedicine™ Restrictive Cardiomyopathy Center

Research & Reviews  525 results

ESC EORP Cardiomyopathy Registry: real-life practice of genetic counselling and testing...
https://doi.org/10.1002/ehf2.12925
ESC Heart Failure References; Heliö T, Elliott P et. al.

Aug 6th, 2020 - Cardiomyopathies comprise a heterogeneous group of diseases, often of genetic origin. We assessed the current practice of genetic counselling and testing in the prospective European Society of Cardiology EURObservational Research Programme Cardiom...

Fast pathway ablation in a patient with PR prolongation.
https://doi.org/10.1111/pace.13983
Pacing and Clinical Electrophysiology : PACE REFERENCES; Tabbah R, Abi-Saleh B

Jun 13th, 2020 - The classical form of typical atrioventricular node reentrant tachycardia (AVNRT) is a "slow-fast" pathways tachycardia, and the usual therapy is an ablation of the slow pathway since it carries a low risk of atrioventricular (AV) block. In patien...

Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the...
https://doi.org/10.1161/CIR.0000000000000792
Circulation Kittleson MM, Maurer MS et. al.

Jun 1st, 2020 - Transthyretin amyloid cardiomyopathy (ATTR-CM) results in a restrictive cardiomyopathy caused by extracellular deposition of transthyretin, normally involved in the transportation of the hormone thyroxine and retinol-binding protein, in the myocar...

Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation.
https://doi.org/10.1016/j.jchf.2019.12.013
JACC. Heart Failure; Barrett CD, Alexander KM et. al.

May 10th, 2020 - The purpose of this study is to report outcomes after heart transplantation in patients with cardiac amyloidosis based on a large single-center experience. Cardiac amyloidosis causes significant morbidity and mortality, often leading to restrictiv...

Disease-Specific Biomarkers in Transthyretin Cardiac Amyloidosis.
https://doi.org/10.1007/s11897-020-00457-z
Current Heart Failure Reports; Hendren NS, Roth LR et. al.

May 1st, 2020 - Transthyretin amyloidosis is an increasingly recognized cause of restrictive cardiomyopathy related to amyloid fibril deposition in cardiac tissues. As treatment therapies have emerged for transthyretin amyloidosis (ATTR), so has interest in using...

see more →

Clinicaltrials.gov  531 results

ESC EORP Cardiomyopathy Registry: real-life practice of genetic counselling and testing...
https://doi.org/10.1002/ehf2.12925
ESC Heart Failure References; Heliö T, Elliott P et. al.

Aug 6th, 2020 - Cardiomyopathies comprise a heterogeneous group of diseases, often of genetic origin. We assessed the current practice of genetic counselling and testing in the prospective European Society of Cardiology EURObservational Research Programme Cardiom...

Fast pathway ablation in a patient with PR prolongation.
https://doi.org/10.1111/pace.13983
Pacing and Clinical Electrophysiology : PACE REFERENCES; Tabbah R, Abi-Saleh B

Jun 13th, 2020 - The classical form of typical atrioventricular node reentrant tachycardia (AVNRT) is a "slow-fast" pathways tachycardia, and the usual therapy is an ablation of the slow pathway since it carries a low risk of atrioventricular (AV) block. In patien...

Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the...
https://doi.org/10.1161/CIR.0000000000000792
Circulation Kittleson MM, Maurer MS et. al.

Jun 1st, 2020 - Transthyretin amyloid cardiomyopathy (ATTR-CM) results in a restrictive cardiomyopathy caused by extracellular deposition of transthyretin, normally involved in the transportation of the hormone thyroxine and retinol-binding protein, in the myocar...

Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation.
https://doi.org/10.1016/j.jchf.2019.12.013
JACC. Heart Failure; Barrett CD, Alexander KM et. al.

May 10th, 2020 - The purpose of this study is to report outcomes after heart transplantation in patients with cardiac amyloidosis based on a large single-center experience. Cardiac amyloidosis causes significant morbidity and mortality, often leading to restrictiv...

Disease-Specific Biomarkers in Transthyretin Cardiac Amyloidosis.
https://doi.org/10.1007/s11897-020-00457-z
Current Heart Failure Reports; Hendren NS, Roth LR et. al.

May 1st, 2020 - Transthyretin amyloidosis is an increasingly recognized cause of restrictive cardiomyopathy related to amyloid fibril deposition in cardiac tissues. As treatment therapies have emerged for transthyretin amyloidosis (ATTR), so has interest in using...

see more →

News  2 results

How to tell constrictive pericarditis from mimickers
https://www.mdedge.com/familymedicine/article/97069/heart-failure/how-tell-constrictive-pericarditis-mimickers/page/0/2
Cardiology News;

Feb 11th, 2015 - A patient with constrictive pericarditis will have enhanced ventricular interaction arising from the restraint imposed by a rigid, diseased pericardium. That’s crucial.

Echo Aids Diagnosis of Constrictive Pericarditis
https://www.mdedge.com/cardiology/article/41523/imaging/echo-aids-diagnosis-constrictive-pericarditis
Bruce Jancin

SNOWMASS, COLO. — Demonstration of enhanced ventricular interaction upon hemodynamic cardiac catheterization is a novel diagnostic criterion for constrictive pericarditis, with far greater predictive accuracy than that of the classic hemodynamic c.

see more →

Patient Education  3 results see all →